Method of using laser scanned point clouds to create selective compression masks

Details for Australian Patent Application No. 2008354776 (hide)

Owner Tele Atlas B.V.

Inventors Hagan, James E.; Kmiecik, Marcin Michal; Wysocki, Arkadiusz

Agent Spruson & Ferguson

Pub. Number AU-A-2008354776

PCT Pub. Number WO2009/128701

Filing date 18 April 2008

Wipo publication date 22 October 2009

International Classifications

H04N 7/26 (2006.01) Television systems - using bandwidth reduction

G06F 17/30 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific functions - Information retrieval

H04N 1/60 (2006.01) Scanning, transmission or reproduction of documents or the like, e.g. facsimile transmission - Colour correction or control

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/128701 Priority application(s): WO2009/128701

23 December 2010 Alteration of Name

  The name of the applicant has been altered to Tele Atlas B.V.; Tele Atlas North America Inc. 2009

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008354794-Treating erythematotelangiectatic rosacea or papulopustular rosacea with narrow-band infrared light radiation and radiation kits therefor

2008354754-On01910. Na enhances chemotherapeutic agent activity in drug-resistant tumors